Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Declines By 34.8%

Edap Tms S.A. (NASDAQ:EDAP) was the target of a large drop in short interest in February. As of February 27th, there was short interest totaling 58,380 shares, a drop of 34.8% from the February 12th total of 89,522 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily volume of 51,440 shares, the short-interest ratio is presently 1.1 days. Based on an average daily volume of 51,440 shares, the short-interest ratio is presently 1.1 days. Approximately 0.2% of the company’s stock are sold short.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on EDAP shares. Wall Street Zen raised Edap Tms to a “hold” rating in a report on Saturday, February 7th. Weiss Ratings reissued a “sell (d-)” rating on shares of Edap Tms in a research report on Monday, December 29th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Edap Tms currently has an average rating of “Hold” and a consensus price target of $8.50.

Institutional Investors Weigh In On Edap Tms

A number of large investors have recently made changes to their positions in EDAP. Financial Planning Navigators CORP purchased a new stake in shares of Edap Tms during the 4th quarter valued at about $33,000. Kovack Advisors Inc. purchased a new position in shares of Edap Tms in the fourth quarter worth approximately $53,000. Leonteq Securities AG bought a new stake in Edap Tms during the fourth quarter valued at approximately $313,000. Flax Pond Capital LLC bought a new stake in Edap Tms during the fourth quarter valued at approximately $2,623,000. Finally, Rock Springs Capital Management LP increased its holdings in Edap Tms by 1.3% during the fourth quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock valued at $4,233,000 after buying an additional 16,500 shares during the last quarter. 62.74% of the stock is currently owned by institutional investors.

Edap Tms Stock Performance

EDAP traded down $0.11 during mid-day trading on Friday, reaching $3.92. 8,020 shares of the company traded hands, compared to its average volume of 54,067. The company’s fifty day moving average price is $4.22 and its 200-day moving average price is $3.06. The stock has a market capitalization of $146.57 million, a P/E ratio of -6.88 and a beta of -0.19. The company has a quick ratio of 0.97, a current ratio of 1.41 and a debt-to-equity ratio of 0.04. Edap Tms has a 52-week low of $1.21 and a 52-week high of $5.05.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.